These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
289 related articles for article (PubMed ID: 8335677)
21. [Prognostic factors in 243 transitional carcinomas of the bladder (II): microscopic parameters of the tumor and staging]. Portillo Martín JA; Val Bernal F; Garijo Ayenza F; Buelta Carrillo L; Martín García B; Hernández Rodríguez R; Gutiérrez Baños JL; Correas Gómez MA; Concepción Masip T; Fernández Gómez JM Arch Esp Urol; 1991 Mar; 44(2):161-8. PubMed ID: 1867491 [TBL] [Abstract][Full Text] [Related]
22. Prognostic factors for primary superficial transitional cell carcinoma of the bladder: a retrospective cohort study. Yang TB; Zeng FH; Sun ZQ Chin Med J (Engl); 2006 Nov; 119(21):1821-8. PubMed ID: 17097038 [TBL] [Abstract][Full Text] [Related]
23. Critical analysis of the 2010 TNM classification in patients with lymph node-positive bladder cancer: influence of lymph node disease burden. Pedrosa JA; Kaimakliotis HZ; Monn MF; Cary KC; Masterson TA; Rice KR; Foster RS; Bihrle R; Koch MO; Cheng L Urol Oncol; 2014 Oct; 32(7):1003-9. PubMed ID: 25027685 [TBL] [Abstract][Full Text] [Related]
24. [Therapy and follow-up of bladder cancer]. Meyer D; Schmid HP; Engeler DS Wien Med Wochenschr; 2007; 157(7-8):162-9. PubMed ID: 17492413 [TBL] [Abstract][Full Text] [Related]
25. The grade and pathologic stage of bladder cancer. Kern WH Cancer; 1984 Mar; 53(5):1185-9. PubMed ID: 6692306 [TBL] [Abstract][Full Text] [Related]
26. Potential of molecular targeted therapy of HER-2 and Cox-2 for invasive transitional cell carcinoma of the urinary bladder. Naruse K; Yamada Y; Nakamura K; Aoki S; Taki T; Zennami K; Katsuda R; Watanabe M; Nishikawa G; Itoh Y; Mitsui K; Hibi H; Honda N Oncol Rep; 2010 Jun; 23(6):1577-83. PubMed ID: 20428812 [TBL] [Abstract][Full Text] [Related]
27. The usefulness of the level of the muscularis mucosae in the staging of invasive transitional cell carcinoma of the urinary bladder. Younes M; Sussman J; True LD Cancer; 1990 Aug; 66(3):543-8. PubMed ID: 2364365 [TBL] [Abstract][Full Text] [Related]
28. Small cell carcinoma of the urinary bladder. A clinicopathologic analysis of 64 patients. Montie JE J Urol; 2005 Jun; 173(6):1920-1. PubMed ID: 15879778 [No Abstract] [Full Text] [Related]
29. Prognosis of muscle-invasive bladder cancer: difference between primary and progressive tumours and implications for therapy. Schrier BP; Hollander MP; van Rhijn BW; Kiemeney LA; Witjes JA Eur Urol; 2004 Mar; 45(3):292-6. PubMed ID: 15036673 [TBL] [Abstract][Full Text] [Related]
30. Natural history of surgically treated bladder carcinoma with extravesical tumor extension. Quek ML; Stein JP; Clark PE; Daneshmand S; Miranda G; Cai J; Groshen S; Lieskovsky G; Quinn DI; Raghavan D; Skinner DG Cancer; 2003 Sep; 98(5):955-61. PubMed ID: 12942562 [TBL] [Abstract][Full Text] [Related]
31. [Prognosis in pT3b infiltrating tumors of the bladder treated by adjuvant chemotherapy]. Sahwi A; Robert M; Delbos O; Legouffe E; Guiter J; Navratil H Prog Urol; 1998 Dec; 8(6):1007-11. PubMed ID: 9894259 [TBL] [Abstract][Full Text] [Related]
32. The prognostic value of the pT-category after combination chemotherapy for patients with invasive bladder cancer who underwent cystectomy. EORTC-GU group. Splinter TA; Scher HI; Denis L; Bukowski R; Soloway M; Vogelzang N; Klimberg I; Dalesio O; Herr H Prog Clin Biol Res; 1990; 353():219-24. PubMed ID: 2217422 [No Abstract] [Full Text] [Related]
33. Histological grading of transitional cell tumours of the bladder. Value of histological grading (WHO) in prognosis. Collan Y; Mäkinen J; Heikkinen A Eur Urol; 1979; 5(5):311-8. PubMed ID: 446506 [TBL] [Abstract][Full Text] [Related]
34. p53 and p21 Expression levels predict organ preservation and survival in invasive bladder carcinoma treated with a combined-modality approach. Garcia del Muro X; Condom E; Vigués F; Castellsagué X; Figueras A; Muñoz J; Solá J; Soler T; Capellà G; Germà JR Cancer; 2004 May; 100(9):1859-67. PubMed ID: 15112266 [TBL] [Abstract][Full Text] [Related]
35. Bladder conservation treatment in the elderly population: results and prognostic factors of muscle-invasive bladder cancer. Tran E; Souhami L; Tanguay S; Rajan R Am J Clin Oncol; 2009 Aug; 32(4):333-7. PubMed ID: 19381080 [TBL] [Abstract][Full Text] [Related]
36. CLINICO-PATHOLOGICAL PATTERN, CLASSIFICATION AND STAGING OF URINARY BLADDER CARCINOMAS--A FIVE YEARS EXPERIENCE AT A TERTIARY CARE HOSPITAL IN CENTRAL PUNJAB. Naeem A; Naseem N; Anwar S; Butt S; Nagi AH J Ayub Med Coll Abbottabad; 2015; 27(1):131-4. PubMed ID: 26182758 [TBL] [Abstract][Full Text] [Related]
37. [Total cystectomy for urinary bladder cancer: clinicopathological study of 95 cases]. Murase T; Takashi M; Aota Y; Shimoji T; Miyake K; Mitsuya H Hinyokika Kiyo; 1985 Apr; 31(4):615-21. PubMed ID: 4036737 [TBL] [Abstract][Full Text] [Related]
38. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy. Yu RJ; Stein JP; Cai J; Miranda G; Groshen S; Skinner DG J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876 [TBL] [Abstract][Full Text] [Related]
39. Squamous differentiation in patients with superficial bladder urothelial carcinoma is associated with high risk of recurrence and poor survival. Li G; Yu J; Song H; Zhu S; Sun L; Shang Z; Niu Y BMC Cancer; 2017 Aug; 17(1):530. PubMed ID: 28789622 [TBL] [Abstract][Full Text] [Related]
40. [Infiltrating transitional cancer of the bladder (2). Prognostic value of the stage. Its influence on the therapeutic decision)]. Escudero Barrilero A; Fernández E; García Cuerpo E; Lovaco F; Navío S; Ruiz C; Serrano A Actas Urol Esp; 1991; 15(3):213-30. PubMed ID: 1927639 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]